Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life sciences technologies and consumables for disease prevention, announces a $42,000 microarray platform sale to a medical research center based in northern Europe. The main instrument in the platform sale is the Arrayit SpotBot® Extreme Protein Edition Microarrayer, which allows scientists and clinicians to analyze proteins quickly and affordably. Proteins, which are the building blocks of all living cells, provide medically important biomarkers for cancer, neurodegenerative disease and other disorders. ARYC’s technology gives customers a competitive advantage in the marketplace by enabling greater assay sensitivity and specificity compared to competing platforms.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
